We are live on ! Find out more
TWST icon

Twist Bioscience

85 hedge funds and large institutions have $402M invested in Twist Bioscience in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 32 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

740% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 5

700% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 4

192% more capital invested

Capital invested by funds: $138M → $402M (+$264M)

73% more funds holding

Funds holding: 4985 (+36)

21.42% more ownership

Funds ownership: 21.43%42.85% (+21%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
85
Holders Change
+36
Holders Change %
+73.47%
% of All Funds
1.85%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
42
Increased
32
Reduced
4
Closed
5
Calls
Puts
Net Calls
Net Calls Change

TWST Hedge Fund Activity: Q2 2019 in Review

85 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q2 2019, worth a combined $402M — up 192% from $138M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new TWST positions and 5 closed out — a net gain of 37 holders — while 32 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $30.9M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.

  • 85 institutional investors held Twist Bioscience (TWST) as of Q2 2019, up from 49 in Q1 2019.
  • Funds reported $402M of Twist Bioscience stock for Q2 2019, up 192% quarter-over-quarter.
  • 42 funds opened new Twist Bioscience positions in Q2 2019 and 5 closed out, a net change of +37 holders.
  • The largest Twist Bioscience buyer in Q2 2019 was BlackRock, an estimated $30.9M added.
  • The largest Twist Bioscience seller in Q2 2019 was Fidelity Investments, an estimated $16.1M sold.

Based on aggregated 13F filings for Q2 2019.